Biosimilars
Biotech
Innovent Biologics Reports Acceptance of BLA for IBI-305 (bevacizumab, biosimilar)
Shots: The BLA is based on two P-III study results assessing efficacy, safety and PK of IBI-305 vs bevacizumab in patients with advanced non-sq NSCLC and has demonstrated in meeting […]readmore